↓ Skip to main content

Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis

Overview of attention for article published in Advances in Rheumatology, February 2021
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#32 of 106)
  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
8 tweeters

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis
Published in
Advances in Rheumatology, February 2021
DOI 10.1186/s42358-021-00170-y
Pubmed ID
Authors

Marina Maria Vieira de Figueiredo Caldas, Kesley Pablo Morais de Azevedo, Ana Clara de França Nunes, Victor Hugo de Oliveira, Isac Davidson Santiago Fernandes Pimenta, Isabela Dantas Torres de Araújo, Francisco Alves Bezerra Neto, Ana Katherine da Silveira Gonçalves de Oliveira, Grasiela Piuvezam

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 13%
Student > Postgraduate 2 13%
Researcher 2 13%
Student > Ph. D. Student 1 7%
Unspecified 1 7%
Other 2 13%
Unknown 5 33%
Readers by discipline Count As %
Medicine and Dentistry 6 40%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Unspecified 1 7%
Business, Management and Accounting 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Other 0 0%
Unknown 5 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 January 2022.
All research outputs
#6,139,873
of 20,756,832 outputs
Outputs from Advances in Rheumatology
#32
of 106 outputs
Outputs of similar age
#150,098
of 438,294 outputs
Outputs of similar age from Advances in Rheumatology
#11
of 35 outputs
Altmetric has tracked 20,756,832 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 106 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.